Publication | Closed Access
A Placebo‐Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa‐Induced Dyskinesia
34
Citations
31
References
2016
Year
AQW051 did not significantly reduce dyskinesia or parkinsonian severity. © 2016 International Parkinson and Movement Disorder Society.
| Year | Citations | |
|---|---|---|
Page 1
Page 1